Interleukin-10 inhibits burst-forming unit erythroid growth by suppression of endogenous granulocyte-macrophage colony-stimulating factor production from T cells

被引:20
作者
Oehler, L
Kollars, M
Bohle, B
Berer, A
Reiter, E
Lechner, K
Geissler, K
机构
[1] Univ Vienna, Div Hematol, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Expt Pathol, A-1090 Vienna, Austria
关键词
burst-forming unit erythroid; interleukin-10; granulocyte-macrophage colony-stimulating factor; T lymphocytes;
D O I
10.1016/S0301-472X(98)00049-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Numerous cytokines released from accessory cells have been shown to exert either stimulatory or inhibitory growth signals on burst-forming unit-erythroid (BFU-E) growth. Because of its cytokine synthesis-inhibiting effects on T cells and monocytes, interleukin-10 (IL-10) may be a potential candidate for indirectly affecting erythropoiesis. We investigated the effects of IL-10 on BFU-E growth from normal human peripheral blood mononuclear cells (PBMC) using a clonogenic progenitor cell assay. The addition of recombinant human IL-10 to cultures containing recombinant human erythropoietin suppressed BFU-E growth in a dose-dependent manner (by 55.2%, range 47.3-63.3%,p < 0.01, at 10 ng/mL), In contrast, no inhibitory effect of IL-10 was seen when cultivating highly enriched CD34(+) cells. BFU-E growth from PBMC also was markedly suppressed in the presence of a neutralizing anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody (by 48.7%, range 32.9-61.2% inhibition,p < 0.01), but not by neutralizing antibodies against granulocyte colony-stimulating factor and interleukin-3, This suggests a stimulatory role of endogenously released GM-CSF on BFU-E formation. Also, the addition of exogenous GM-CSF completely restored IL-10-induced suppression of BFU-E growth. To determine the cellular source of GM-CSF production, we analyzed GM-CSF levels in suspension cultures containing PBMC that were either depleted of monocytes or T cells. Monocyte-depleted PBMC showed spontaneous production of increasing amounts of GMCSF on days 3, 5, and 7, respectively, which could be suppressed by IL-10, whereas GM-CSP levels did not increase in cultures containing T-cell-depleted PBMC, Our data indicate that IL-10 inhibits the growth of erythroid progenitor cells in vitro, most likely by suppression of endogenous GM-CSF production from T cells. (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 47 条
[1]   Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell B cell antibody synthesis [J].
AlJanadi, M ;
AlDalaan, A ;
AlBalla, S ;
AlHumaidi, M ;
Raziuddin, S .
JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (04) :198-207
[2]   BLUNTED ERYTHROPOIETIN RESPONSE TO ANEMIA IN RHEUMATOID-ARTHRITIS [J].
BAER, AN ;
DESSYPRIS, EN ;
GOLDWASSER, E ;
KRANTZ, SB .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) :559-564
[3]  
BROXMEYER HE, 1983, J IMMUNOL, V131, P1300
[4]   INTERLEUKIN-10 DIFFERENTIALLY REGULATES B7-1 (CD80) AND B7-2 (CD86) EXPRESSION ON HUMAN PERIPHERAL-BLOOD DENDRITIC CELLS [J].
BUELENS, C ;
WILLEMS, F ;
DELVAUX, A ;
PIERARD, G ;
DELVILLE, JP ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (09) :2668-2672
[5]  
CARTWRIGHT GE, SEMIN HEMATOL, V3, P351
[6]  
CHERNOFF AE, 1995, J IMMUNOL, V154, P5492
[7]   ELEVATED INTERLEUKIN-10 LEVELS IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
CUSH, JJ ;
SPLAWSKI, JB ;
THOMAS, R ;
MCFARLIN, JE ;
SCHULZEKOOPS, H ;
DAVIS, LS ;
FUJITA, K ;
LIPSKY, PE .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :96-104
[8]   HUMORAL SUPPRESSION OF ERYTHROPOIESIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND RHEUMATOID-ARTHRITIS [J].
DAINIAK, N ;
HARDIN, J ;
FLOYD, V ;
CALLAHAN, M ;
HOFFMAN, R .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :537-544
[9]  
DE WMR, 1991, J EXP MED, V174, P1209
[10]   Concepts of hemopoietic cell amplification, synergy, redundancy and pleiotropy of cytokines affecting the regulation of erythropoiesis [J].
deHaan, G ;
Dontje, B ;
Nijhof, W .
LEUKEMIA & LYMPHOMA, 1996, 22 (5-6) :385-394